Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasi

BACKGROUND: Patients with New World cutaneous leishmaniasis (NWCL) caused by Leishmania Viannia are treated with parenteral sodium stibogluconate (SbV) to reduce the risk of development of mucocutanous leishmaniasis. Our centre manages patients with NWCL on an outpatient-basis. This study was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wise, Emily S., Armstrong, Margaret S., Watson, Julie, Lockwood, Diana N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383730/
https://www.ncbi.nlm.nih.gov/pubmed/22745840
http://dx.doi.org/10.1371/journal.pntd.0001688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383730/
https://www.ncbi.nlm.nih.gov/pubmed/22745840
http://dx.doi.org/10.1371/journal.pntd.0001688

Ejemplares similares